GLP-2
Tirzepatide for weight loss — what it is, how it works, and what the trials show Tirzepatide (brand names include Mounjaro for diabetes and Zepbound for obesity in some markets) is a novel, dual-agonist peptide that activates two incretin hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It was […]
GLP-3
What is retatrutide Retatrutide is an experimental peptide drug developed by Eli Lilly. It is a triple receptor agonist: it activates three hormonal receptors involved in metabolism and appetite regulation: The idea is that combining signaling through these three receptors can yield greater weight loss and metabolic benefit than targeting one or two alone. New […]